Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Get Regular Insights on Regulatory, Legislative, and Payment Issues From APTA

Apr 17, 2024/News

Free to members, APTA's webinar series delivers crucial information in an easy-to-understand format. Register now for upcoming sessions.

Medicare Telehealth Flexibilities Extended Through Dec. 31, 2027

Feb 4, 2026/Article

Congress voted on Tuesday, Feb. 3, to pass an appropriations package that will fund the government for the fiscal year 2026. Included in this minibus spending package, among other items, is funding for a two-year extension of Medicare telehealth flexibilities and funding for a one-year extension of the

Dismantling the 'Industrial Medical Complex'

Sep 14, 2021/News

The 2021 Maley Lecture was a sobering look at what health care is getting wrong — and a hopeful call for PTs and PTAs to set things right.

Get to Know APTA Home Health: An Interview With Academy President Philip Goldsmith

Dec 10, 2024/Podcast

A brief introduction from the president of the academy.

The Real Value of Physical Therapy: APTA Report Proves Its Worth

Sep 1, 2025/Feature

Learn how people are using "The Economic Value of Physical Therapy in the United States" to make the case that physical therapy is cost-effective.

Contact a PT Student

Making a career choice is a big decision, and you probably have questions.

The Best-Laid 10-Year Plan ...

Jul 1, 2022/Column

A former newscaster trades the thrill of chasing down a story for the higher satisfaction of improving patients' lives.

APTA Centennial Scholars Spotlight

Nov 1, 2022/Column

This month, APTA Magazine spotlights APTA Centennial Scholar Monique Pineros, PT, DPT.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).